SHARON ABUEG: Open Payments
NPI 1801433917 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 14 payments from 6 companies in 2025. Trend: 2023 $15 · 2024 $225 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Merck Sharp & Dohme LLC | 3 | $75 |
| PFIZER INC. | 3 | $47 |
| Novo Nordisk Inc | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| BridgeBio Pharma, Inc. | 1 | $15 |
Products named: VERQUVO, ELIQUIS, CAMZYOS, VYNDAQEL, JARDIANCE, Ozempic, Wegovy, Attruby.
Industry payments across MD — which companies pay providers there.
